In an essay I published last year for the Lasker Essay Contest (and republished in our blog), I described optogenetics and chemogenetics, two technologies recently developed for basic neuroscience research that have the potential to improve the way we treat psychiatric illness. The major drawback to drugs currently prescribed for diseases such as depression, PTSD,(...)
PTSD
Ecstasy and Agony: Accepting MDMA-Assisted Psychotherapy as a Breakthrough PTSD Treatment
Posted by Benjamin Bell | Perspectives in Research, Recently PublishedFor the majority of the population, MDMA, or ecstasy, is simply an illegal drug, its use exclusive to underground dance clubs and its abuse the purview of the police. However, a small group of psychopharmacological researchers and advocates have been touting this compound as the next major frontline treatment for a variety of troubling psychological(...)
Oct 4, 2017